LONGEVITY OF RABIES ANTIBODY TITER IN RECIPIENTS OF HUMAN-DIPLOID CELL RABIES VACCINE

被引：38
|
作者：
BRIGGS, DJ [1 ]
SCHWENKE, JR [1 ]
机构：
[1] KANSAS STATE UNIV AGR & APPL SCI,DEPT STAT,MANHATTAN,KS 66506
来源：
VACCINE | 1992年 / 10卷 / 02期
关键词：
RABIES; VACCINE; INTRAMUSCULAR; INTRADERMAL; LONGEVITY;
D O I：
10.1016/0264-410X(92)90029-J
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Sera from individuals across the USA and Peace Corps Volunteers (PCV) were assayed for neutralizing antibody to human diploid cell rabies vaccine (HDCV). A pairwise comparison between intramuscular (i.m.) and intradermal (i.d.) administration, PCV and non-PCV, revealed statistically significant differences between i.m. and i.d. for PCV and non-PCV, and between PCV and non-PCV for i.d. and i.m. administration. Survival analysis and frequency tables employing chi(2) tests determined that the percentage probability of maintaining an adequate titre from 1.5-2.0 years after primary vaccination was 99% in non-PCV i.m., 93% in non-PCV i.d., 88% in PCV i.m., and 64% in PCV i.d.
引用
收藏
页码：125 / 129
页数：5
相关论文
共 50 条
  • [41] PREEXPOSURE PROPHYLAXIS IN PEACE CORPS VOLUNTEERS WITH INTRADERMAL HUMAN-DIPLOID CELL RABIES VACCINE
    ROSA, FW
    JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1983, 86 (02): : 81 - 84
  • [42] HUMAN DIPLOID CELL STRAIN RABIES VACCINE
    NANAVATI, AND
    LANCET, 1976, 2 (7986): : 641 - 641
  • [43] PURIFIED VERO CELL RABIES VACCINE AND HUMAN-DIPLOID CELL STRAIN VACCINE - COMPARISON OF NEUTRALIZING ANTIBODY-RESPONSES TO POSTEXPOSURE REGIMENS
    SUNTHARASAMAI, P
    CHANTHAVANICH, P
    WARRELL, MJ
    LOOAREESUWAN, S
    KARBWANG, J
    SUPANARANOND, W
    PHILLIPS, RE
    JANSAWAN, W
    XUEREF, C
    POURADIERDUTEIL, X
    WARRELL, DA
    JOURNAL OF HYGIENE, 1986, 96 (03) : 483 - 489
  • [44] HUMAN RABIES AFTER LATE ADMINISTRATION OF HUMAN-DIPLOID CELL VACCINE WITHOUT HYPERIMMUNE SERUM
    WATTANASRI, S
    BOONTHAI, P
    THONGCHAROEN, P
    LANCET, 1982, 2 (8303): : 870 - 870
  • [45] PERSISTENCE OF ANTI-RABIES ANTIBODY AND BOOSTER USE OF RABIES HUMAN DIPLOID-CELL VACCINE (HDCV)
    BOMZE, J
    ROSANOFF, G
    COPENHAVER, T
    DEITCH, M
    CLINICAL RESEARCH, 1982, 30 (05): : A851 - A851
  • [46] BOOSTER EFFECT OF HUMAN-DIPLOID CELL ANTI-RABIES VACCINE IN PREVIOUSLY TREATED PERSONS
    FAYAZ, A
    SIMANI, S
    NOURSALEHI, S
    BAHMANYAR, M
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1981, 246 (20): : 2334 - 2335
  • [47] INTRADERMAL IMMUNIZATION USING HUMAN-DIPLOID CELL RABIES VACCINE - A 2-YEAR STUDY
    HOWARD, DR
    JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1984, 185 (03) : 328 - 328
  • [48] TRIAL OF HUMAN DIPLOID CELL RABIES VACCINE IN HUMAN VOLUNTEERS
    SHAH, U
    JASWAL, GS
    MANSHARAMANI, HJ
    PLOTKIN, SA
    WIKTOR, TJ
    BRITISH MEDICAL JOURNAL, 1976, 1 (6016): : 997 - 997
  • [49] INTERFERON RESPONSE TO HUMAN-DIPLOID CELL STRAIN RABIES VACCINES IN MAN
    NICHOLSON, KG
    KUWERT, EK
    WERNER, J
    HARRISON, P
    ARCHIVES OF VIROLOGY, 1979, 61 (1-2) : 35 - 39
  • [50] IMMUNIZATION AGAINST RABIES WITH RABIES IMMUNE GLOBULIN, HUMAN (RIGH) AND A HUMAN DIPLOID CELL STRAIN (HDCS) RABIES VACCINE
    KUWERT, EK
    WERNER, J
    MARCUS, I
    CABASSO, VJ
    JOURNAL OF BIOLOGICAL STANDARDIZATION, 1978, 6 (03): : 211 - 219
12345